AUG 31, 2021 9:00 AM PDT

The Regulation of ALC1 by TRIM33 during the DNA Damage Response

Speaker

Abstract
Date:  August 31, 2021
Time: 9:00am (PDT),  12:00pm (EDT)
 
The DNA damage response is extremely crucial in maintaining genomic integrity. Failure to repair damaged DNA can result in the propagation of mutations and lesions that can contribute to tumorigenesis. The poly [ADP-ribose] polymerase (PARP), is a DNA damage response protein that is transiently recruited to sites of DNA breaks, and is involved in the signaling and recruitment of other important DNA damage response proteins. PARP is involved in the regulation of the chromatin remodeling enzyme, Amplified in Liver Cancer 1 (ALC1). ALC1 functions as a chromatin remodeler, and studies from our laboratory has shown that ALC1 interacts with the E3 ubiquitin-protein ligase, Tripartite Motif-containing 33 (TRIM33) during DDR. TRIM33 has been known to play a role in numerous biological process such as tumorigenesis, TGF-B signaling and transcriptional regulation. We have observed that TRIM33 is recruited to sites of DNA breaks after the activation of PARP, and interacts with ALC1. TRIM33-deficient cells have shown to exhibit sensitivity to DNA damage, with the subsequent and prolonged retention of ALC1 at the sites of DNA breaks. Prolonged chromatin relaxation facilitated by ALC1 leads to increased sensitivity to DNA damaging agents. This sensitivity can be overcome with the overexpression of TRIM33. Our laboratory has demonstrated that TRIM33 regulates the activity of ALC1 during DNA repair by facilitating the timely removal of ALC1 at the sites of DNA breaks, thus promoting efficient DNA repair. There is current research focus that aims to investigate the dynamics of TRIM33 and ALC1, and their interactions with other key proteins involved in DNA repair, especially those proteins that are differentially regulated.
 
Learning Objectives
 
  • Describe and understand the mechanisms of DNA Repair
  • Discuss how the PARP dependent DNA damage response pathway is regulated
  • Discuss and understand how key proteins involved in DDR including TRIM33 and ALC1 can serve as actionable targets in the treatment of certain cancer
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
JUN 24, 2021 10:00 AM PDT
C.E. CREDITS
JUN 24, 2021 10:00 AM PDT
Date: June 24, 2021 Time: 10:00am PDT The Chan Zuckerberg Initiative (CZI) was founded to help solve some of society’s toughest challenges— from eradicating disease and improving...
SEP 08, 2021 9:00 AM PDT
SEP 08, 2021 9:00 AM PDT
Date: September 8, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Implanted biomedical devices comprise a major component of modern medicine and are essential for many clinical applications ranging...
Loading Comments...
Show Resources